Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): October 30, 2014 (October 29, 2014)

 

 

Acadia Healthcare Company, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-35331   46-2492228

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

830 Crescent Centre Drive, Suite 610

Franklin, Tennessee

  37067
(Address of Principal Executive Offices)   (Zip Code)

(615) 861-6000

(Registrant’s Telephone Number, including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 Results of Operations and Financial Condition.

On October 29, 2014, Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) issued a press release announcing, among other things, Acadia’s operating and financial results for the third quarter and nine months ended September 30, 2014. The press release is furnished herewith as Exhibit 99.1 hereto and is incorporated herein by reference.

 

Item 7.01 Regulation FD Disclosure.

On October 29, 2014, Acadia also announced the signing of a definitive agreement to acquire CRC Health Group, Inc. (“CRC”), the nation’s largest specialized behavioral healthcare provider. CRC provides substance abuse treatment and other specialty programs through 36 residential facilities and 84 comprehensive treatment facilities that currently treat approximately 40,000 patients daily. The press release is furnished herewith as Exhibit 99.1 hereto and is incorporated herein by reference.

The Company will hold a conference call to discuss its third quarter financial results and the pending acquisition of CRC at 9:00 a.m. Eastern Time on Thursday, October 30, 2014. A live webcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of the conference call will be available through November 14, 2014.

The press release shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, unless the Company specifically incorporates it by reference in a document filed under the Securities Act of 1933 or the Securities Exchange Act of 1934.

 

Item 9.01. Financial Statements and Exhibits.

 

  (d) Exhibits.

 

Exhibit
Number

 

Description

99.1   Press Release dated October 29, 2014


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ACADIA HEALTHCARE COMPANY, INC.

Date: October 30, 2014

    By:  

/s/ Christopher Howard

      Christopher L. Howard
      Executive Vice President, Secretary and General
Counsel


EXHIBIT INDEX

 

Exhibit
Number

 

Description

99.1   Press Release dated October 29, 2014
EX-99.1

Exhibit 99.1

LOGO

Contact:

Brent Turner

President

(615) 861-6000

Acadia Healthcare Reports Third Quarter Adjusted Earnings Increase to

$0.46 per Diluted Share on Revenue of $294.5 million

 

 

Announces Definitive Agreement for $1.175 Billion Acquisition of CRC Health Group

 

 

Raises 2014 Guidance for Adjusted Earnings per Diluted Share to Range of

$1.52 to $1.53 from Previous Range of $1.44 to $1.46

FRANKLIN, Tenn. October 29, 2014 – Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the third quarter and nine months ended September 30, 2014. For the quarter, revenue increased 59.4% to $294.5 million from $184.7 million for the third quarter of 2013. Income from continuing operations was $25.5 million, or $0.43 per diluted share, for the third quarter of 2014 compared with $14.5 million, or $0.29 per diluted share, for the third quarter of 2013. Adjusted income from continuing operations rose 79.5% to $27.3 million for the third quarter of 2014 from $15.2 million for the third quarter of 2013, while adjusted income from continuing operations per diluted share increased 53.3% to $0.46 from $0.30. For the third quarter of 2014, the adjusted results exclude transaction-related expenses of $6.2 million and a gain on foreign currency derivatives of $1.5 million that was related to Acadia’s recent acquisition of Partnerships in Care (PiC). For the third quarter of 2013, the adjusted results exclude transaction-related expenses of $1.0 million. Weighted average shares outstanding increased 18.0% for the third quarter of 2014 from the third quarter of 2013 primarily due to the Company’s public equity offering in June, 2014. A reconciliation of all GAAP and non-GAAP financial results in this release is on pages 8 and 9.

Revenue for the first nine months of 2014 was $709.7 million, a 35.6% increase from $523.4 million for the first nine months of 2013. Income from continuing operations was $60.9 million, or $1.13 per diluted share, for the first nine months of 2014 compared with $30.9 million, or $0.61 per diluted share, for the same period in 2013. Adjusted income from continuing operations was $57.9 million for the first nine months of 2014, up 48.0% from $39.1 million for the first nine months of 2013, while adjusted income from continuing operations per diluted share increased 37.2% to $1.07 from $0.78. The adjusted results exclude a gain on foreign currency derivatives of $15.3 million for the first nine months of 2014, debt extinguishment costs of $9.4 million for the first nine months of 2013 and transaction-related expenses of $10.8 million and $3.8 million for the first nine months of 2014 and 2013, respectively. Weighted average shares outstanding increased 7.4% for the first nine months of 2014 from the same period in 2013.

“Acadia achieved very strong profitable growth for the third quarter of 2014, as both our organic and acquisition growth strategies produced strong results,” said Joey Jacobs, Chairman and Chief Executive Officer of Acadia. “We were pleased to complete the acquisition of PiC during the third quarter, which is the U.K.’s second-largest independent behavioral healthcare provider. The PiC transaction added 23 inpatient psychiatric facilities with over 1,200 licensed beds to Acadia’s operations and was meaningfully accretive to our third quarter results. In addition, during the third quarter we acquired McCallum Place, an eating disorder treatment facility with 85 beds offering residential, partial hospitalization and intensive outpatient treatment programs located in St. Louis, Missouri, and Austin, Texas.

 

- MORE -


ACHC Reports Third Quarter Results

Page 2

October 29, 2014

 

“Today, we are also announcing a definitive agreement for the acquisition of CRC Health Group Inc., the nation’s largest specialized behavioral healthcare provider. CRC, headquartered in Cupertino, California, provides substance abuse treatment and other specialty programs through 36 residential facilities and 84 comprehensive treatment facilities that currently treat approximately 40,000 patients daily. These facilities are expected to produce aggregate revenues for 2014 of approximately $450 million and adjusted EBITDA of approximately $115 million. Consideration for the acquisition of privately held CRC is $1.175 billion, consisting of up to approximately 6.3 million shares of Acadia’s common stock and the assumption of CRC’s debt. We expect to complete this accretive transaction, which is subject to normal closing conditions, in the first quarter of 2015.

“Including the PiC and McCallum Place transactions in the third quarter, Acadia completed five acquisitions in the 12 months ended September 30, 2014, that brought 27 facilities and more than 1,500 licensed beds to the Company. During this 12 month period, we also added approximately 410 new beds to existing facilities and through the opening of two de novo facilities and one facility that was under construction when acquired in the second quarter last year. We added 40 of these new beds during the third quarter of 2014, including seven new beds within PiC.

“The new beds added to existing U.S. facilities in our same facility base since the end of the third quarter last year significantly contributed to same facility revenue growth of 9.9% in our operations for the third quarter of 2014. We also continuously work to drive same-facility revenue growth through facility specific initiatives to generate additional revenue growth in every facility. The growth in same-facility revenue for the third quarter reflected an 11.2% increase in patient days for the quarter and 1.2% lower revenue per patient day.

“The substantial increase in same facility revenue growth for the third quarter, combined with increased operating efficiencies, produced a 130 basis point increase in our same facility EBITDA margin to 25.8%. The Company’s adjusted consolidated EBITDA increased 69.1% to $65.1 million for the third quarter of 2014, which is 22.1% of revenue compared with 20.8% for the third quarter last year.

“We continue to evaluate potential acquisitions in the highly fragmented behavioral healthcare markets in the U.S. and the U.K., as well as to add new beds in existing facilities. We are well positioned to finance these growth strategies, with availability under our revolving credit facility of approximately $136 million at September 30, 2014 and with substantial net cash flows from continuing operations, which totaled approximately $40 million for the third quarter and $69 million for the first nine months of 2014. Our ratio of total net debt to trailing 12 months adjusted EBITDA was approximately 4.0 at the end of the third quarter compared with 4.2 at the end of the second quarter of 2014.”

 

- MORE -


ACHC Reports Third Quarter Results

Page 3

October 29, 2014

 

Acadia today raised its guidance for 2014 adjusted earnings per diluted share to a range of $1.52 to $1.53 from the previous range of $1.44 to $1.46. The Company’s guidance does not include the impact of any future acquisitions or transaction-related expenses.

Acadia will hold a conference call to discuss its third quarter financial results and the pending CRC transaction at 9:00 a.m. Eastern Time on Thursday, October 30, 2014. A live webcast of the conference call will be available at www.acadiahealthcare.com in the “Investor Relations” section of the website. The webcast of the conference call will be available through November 14, 2014.

Risk Factors

This news release contains forward-looking statements. Generally words such as “may,” “will,” “should,” “could,” “anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,” and “believe” or the negative of or other variation on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this news release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are based on current expectations and involve risks and uncertainties and our future results could differ significantly from those expressed or implied by our forward-looking statements. Factors that may cause actual results to differ materially include, without limitation, (i) Acadia’s ability to complete acquisitions, including the acquisition of CRC, and successfully integrate the operations of acquired facilities, including the PiC facilities; (ii) Acadia’s ability to add beds, expand services, enhance marketing programs and improve efficiencies at its facilities; (iii) potential reductions in payments received by Acadia from the government and third-party payors; (iv) the occurrence of patient incidents, which could adversely affect the price of our common stock and result in incremental regulatory burdens and governmental investigations; (v) the risk that Acadia may not generate sufficient cash from operations to service its debt and meet its working capital and capital expenditure requirements; and (vi) potential operating difficulties, client preferences, changes in competition and general economic or industry conditions that may prevent Acadia from realizing the expected benefits of its business strategy. These factors and others are more fully described in Acadia’s periodic reports and other filings with the SEC.

About Acadia

Acadia is a provider of inpatient behavioral healthcare services. Acadia operates a network of 76 behavioral healthcare facilities with approximately 5,800 licensed beds in 24 states, the United Kingdom and Puerto Rico. Acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs.

 

- MORE -


ACHC Reports Third Quarter Results

Page 4

October 29, 2014

 

Acadia Healthcare Company, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

 

     September 30,     December 31,  
     2014     2013  
     (In thousands)  
ASSETS     

Current assets:

    

Cash and cash equivalents

   $ 42,179      $ 4,569   

Accounts receivable, net of allowance for doubtful accounts of $21,730 and $18,345, respectively

     130,253        95,885   

Deferred tax assets

     19,782        15,703   

Other current assets

     37,626        28,969   
  

 

 

   

 

 

 

Total current assets

     229,840        145,126   

Property and equipment, net

     1,026,378        370,109   

Goodwill

     804,647        661,549   

Intangible assets, net

     21,621        20,568   

Deferred tax assets—noncurrent

     15,933        —     

Other assets

     42,049        27,307   
  

 

 

   

 

 

 

Total assets

   $ 2,140,468      $ 1,224,659   
  

 

 

   

 

 

 
LIABILITIES AND EQUITY     

Current liabilities:

    

Current portion of long-term debt

   $ 13,320      $ 15,195   

Accounts payable

     43,260        36,026   

Accrued salaries and benefits

     56,213        37,721   

Other accrued liabilities

     29,747        25,748   
  

 

 

   

 

 

 

Total current liabilities

     142,540        114,690   

Long-term debt

     1,016,002        601,941   

Deferred tax liabilities—noncurrent

     64,771        7,971   

Other liabilities

     30,579        19,347   
  

 

 

   

 

 

 

Total liabilities

     1,253,892        743,949   

Equity:

    

Common stock

     592        501   

Additional paid-in capital

     843,528        461,807   

Accumulated other comprehensive loss

     (36,857     —     

Retained earnings

     79,313        18,402   
  

 

 

   

 

 

 

Total equity

     886,576        480,710   
  

 

 

   

 

 

 

Total liabilities and equity

   $ 2,140,468      $ 1,224,659   
  

 

 

   

 

 

 

 

- MORE -


ACHC Reports Third Quarter Results

Page 5

October 29, 2014

 

Acadia Healthcare Company, Inc.

Condensed Consolidated Statements of Income

(Unaudited)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2014     2013     2014     2013  
     (In thousands, except per share amounts)  

Revenue before provision for doubtful accounts

   $ 303,001      $ 190,574      $ 729,784      $ 539,230   

Provision for doubtful accounts

     (8,522     (5,872     (20,084     (15,821
  

 

 

   

 

 

   

 

 

   

 

 

 

Revenue

     294,479        184,702        709,700        523,409   

Salaries, wages and benefits (including equity-based compensation expense of $2,805, $1,331, $6,975 and $3,744, respectively)

     168,632        103,789        408,680        298,904   

Professional fees

     14,878        8,956        36,151        27,294   

Supplies

     14,062        9,806        34,722        28,017   

Rents and leases

     3,214        2,656        8,872        7,377   

Other operating expenses

     31,432        22,345        79,188        59,424   

Depreciation and amortization

     10,325        4,414        21,696        12,248   

Interest expense, net

     14,068        9,465        33,505        27,672   

Debt extinguishment costs

     —          —          —          9,350   

Gain on foreign currency derivatives

     (1,527     —          (15,262     —     

Transaction-related expenses

     6,239        984        10,834        3,813   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

     261,323        162,415        618,386        474,099   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     33,156        22,287        91,314        49,310   

Provision for income taxes

     7,703        7,741        30,383        18,439   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations

     25,453        14,546        60,931        30,871   

Loss from discontinued operations, net of income taxes

     (51     (182     (20     (572
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 25,402      $ 14,364      $ 60,911      $ 30,299   
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic earnings per share:

        

Income from continuing operations

   $ 0.43      $ 0.29      $ 1.14      $ 0.62   

Loss from discontinued operations

     —          —          —          (0.01
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 0.43      $ 0.29      $ 1.14      $ 0.61   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted earnings per share:

        

Income from continuing operations

   $ 0.43      $ 0.29      $ 1.13      $ 0.61   

Loss from discontinued operations

     —          —          —          (0.01
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 0.43      $ 0.29      $ 1.13      $ 0.60   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average shares outstanding:

        

Basic

     59,175        50,040        53,670        49,987   

Diluted

     59,409        50,343        53,922        50,213   

 

- MORE -


ACHC Reports Third Quarter Results

Page 6

October 29, 2014

 

Acadia Healthcare Company, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

     Nine Months Ended
September 30,
 
     2014     2013  
     (In thousands)  

Operating activities:

    

Net income

   $ 60,911      $ 30,299   

Adjustments to reconcile net income to net cash provided by continuing operating activities:

    

Depreciation and amortization

     21,696        12,248   

Amortization of debt issuance costs

     2,229        1,686   

Equity-based compensation expense

     6,975        3,744   

Deferred income tax expense

     4,645        10,545   

Loss from discontinued operations, net of taxes

     20        572   

Debt extinguishment costs

     —          9,350   

Gain on foreign currency derivatives

     (15,262     —     

Other

     163        16   

Change in operating assets and liabilities, net of effect of acquisitions:

    

Accounts receivable, net

     (25,395     (18,378

Other current assets

     1,322        (5,657

Other assets

     (2,086     (1,676

Accounts payable and other accrued liabilities

     1,078        2,596   

Accrued salaries and benefits

     8,972        (2,114

Other liabilities

     3,805        3,538   
  

 

 

   

 

 

 

Net cash provided by continuing operating activities

     69,073        46,769   

Net cash used in discontinued operating activities

     (27     (541
  

 

 

   

 

 

 

Net cash provided by operating activities

     69,046        46,228   

Investing activities:

    

Cash paid for acquisitions, net of cash acquired

     (722,797     (135,605

Cash paid for capital expenditures

     (70,680     (50,678

Cash paid for real estate acquisitions

     (22,247     (4,676

Settlement of foreign currency derivatives

     15,262        —     

Other

     (733     (1,088
  

 

 

   

 

 

 

Net cash used in investing activities

     (801,195     (192,047

Financing activities:

    

Borrowings on long-term debt

     307,500        150,000   

Borrowings on revolving credit facility

     230,500        27,500   

Principal payments on revolving credit facility

     (120,000     (8,000

Principal payments on long-term debt

     (5,625     (5,625

Repayment of long-term debt

     —          (52,500

Payment of debt issuance costs

     (10,909     (4,307

Payment of premium on note redemption

     —          (6,759

Issuance of common stock, net

     374,431        —     

Common stock withheld for minimum statutory taxes, net

     (3,477     (1,120

Excess tax benefit from equity awards

     3,779        1,265   

Cash paid for contingent consideration

     (5,000     —     
  

 

 

   

 

 

 

Net cash provided by financing activities

     771,199        100,454   
  

 

 

   

 

 

 

Effect of exchange rate changes on cash

     (1,440     —     
  

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     37,610        (45,365

Cash and cash equivalents at beginning of the period

     4,569        49,399   
  

 

 

   

 

 

 

Cash and cash equivalents at end of the period

   $ 42,179      $ 4,034   
  

 

 

   

 

 

 
   $ —       

Effect of acquisitions:

    

Assets acquired, excluding cash

   $ 802,767      $ 163,706   

Liabilities assumed

     (78,003     (16,417

Prior year deposits paid for acquisitions

     (500     (11,684

Contingent consideration issued in connection with acquisition

     (1,467     —     
  

 

 

   

 

 

 

Cash paid for acquisitions, net of cash acquired

   $ 722,797      $ 135,605   
  

 

 

   

 

 

 

 

- MORE -


ACHC Reports Third Quarter Results

Page 7

October 29, 2014

 

Acadia Healthcare Company, Inc.

Operating Statistics

(Unaudited)

(Revenue in thousands)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2014     2013     % Change     2014     2013     % Change  

Same Facility Results

            

Revenue

   $ 202,344      $ 184,071        9.9   $ 575,735      $ 521,368        10.4

Patient Days

     307,247        276,193        11.2     866,025        788,383        9.8

Admissions

     17,763        14,804        20.0     48,331        41,870        15.4

Average Length of Stay (a)

     17.3        18.7        -7.3     17.9        18.8        -4.8

Revenue per Patient Day

   $ 659      $ 666        -1.2   $ 665      $ 661        0.5

EBITDA margin

     25.8     24.5     130 bps        26.0     24.2     180 bps   

U.S. Facility Results

            

Revenue

   $ 217,427      $ 184,071        18.1   $ 630,825      $ 521,368        21.0

Patient Days

     326,479        276,193        18.2     939,246        788,383        19.1

Admissions

     19,949        14,804        34.8     56,775        41,870        35.6

Average Length of Stay (a)

     16.4        18.7        -12.3     16.5        18.8        -12.1

Revenue per Patient Day

   $ 666      $ 666        -0.1   $ 672      $ 661        1.6

EBITDA margin

     24.8     24.5     30 bps        24.5     24.2     30 bps   

U.K. Facility Results

            

Revenue

   $ 76,026          $ 76,026       

Patient Days

     95,375            95,375       

Admissions

     319            319       

Average Length of Stay (a)

     299.0            299.0       

Revenue per Patient Day

   $ 797          $ 797       

EBITDA margin

     26.6         26.6    

Total Facility Results

            

Revenue

   $ 293,453      $ 184,071        59.4   $ 706,851      $ 521,368        35.6

Patient Days

     421,854        276,193        52.7     1,034,621        788,383        31.2

Admissions

     20,268        14,804        36.9     57,094        41,870        36.4

Average Length of Stay (a)

     20.8        18.7        11.6     18.1        18.8        -3.8

Revenue per Patient Day

   $ 696      $ 666        4.4   $ 683      $ 661        3.3

EBITDA margin

     25.2     24.5     70 bps        24.7     24.2     50 bps   

 

(a) Average length of stay is defined as patient days divided by admissions.

 

- MORE -


ACHC Reports Third Quarter Results

Page 8

October 29, 2014

 

Acadia Healthcare Company, Inc.

Reconciliation of Net Income to Adjusted EBITDA

(Unaudited)

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
     2014     2013      2014     2013  
     (in thousands)  

Net income

   $ 25,402      $ 14,364       $ 60,911      $ 30,299   

Loss from discontinued operations

     51        182         20        572   

Provision for income taxes

     7,703        7,741         30,383        18,439   

Interest expense, net

     14,068        9,465         33,505        27,672   

Depreciation and amortization

     10,325        4,414         21,696        12,248   
  

 

 

   

 

 

    

 

 

   

 

 

 

EBITDA

     57,549        36,166         146,515        89,230   

Adjustments:

         

Equity-based compensation expense (a)

     2,805        1,331         6,975        3,744   

Debt extinguishment costs (b)

     —          —           —          9,350   

Gain on foreign currency derivatives (c)

     (1,527     —           (15,262     —     

Transaction-related expenses (d)

     6,239        984         10,834        3,813   
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted EBITDA

   $ 65,066      $ 38,481       $ 149,062      $ 106,137   
  

 

 

   

 

 

    

 

 

   

 

 

 

See footnotes on page 10.

 

- MORE -


ACHC Reports Third Quarter Results

Page 9

October 29, 2014

 

Acadia Healthcare Company, Inc.

Reconciliation of Adjusted Income from Continuing Operations to Income from

Continuing Operations

(Unaudited)

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2014     2013     2014     2013  
     (in thousands, except per share amounts)  

Income from continuing operations

   $ 25,453      $ 14,546      $ 60,931      $ 30,871   

Provision for income taxes

     7,703        7,741        30,383        18,439   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     33,156        22,287        91,314        49,310   

Adjustments to income from continuing operations:

        

Debt extinguishment costs (b)

     —          —          —          9,350   

Gain on foreign currency derivatives (c)

     (1,527     —          (15,262     —     

Transaction-related expenses (d)

     6,239        984        10,834        3,813   

Income tax provision reflecting tax effect of adjustments to income from continuing operations (e)

     (10,603     (8,082     (29,016     (23,359
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted income from continuing operations

   $ 27,265      $ 15,189      $ 57,870      $ 39,114   

Weighted-average shares outstanding—diluted

     59,409        50,343        53,922        50,213   

Adjusted income from continuing operations per diluted share

   $ 0.46      $ 0.30      $ 1.07      $ 0.78   
  

 

 

   

 

 

   

 

 

   

 

 

 

See footnotes on page 10.

 

- MORE -


ACHC Reports Third Quarter Results

Page 10

October 29, 2014

 

Acadia Healthcare Company, Inc.

Footnotes

We have included certain financial measures in this press release, including EBITDA, Adjusted EBITDA and Adjusted income from continuing operations, which are “non-GAAP financial measures” as defined under the rules and regulations promulgated by the SEC. We define EBITDA as net income adjusted for loss (income) from discontinued operations, net interest expense, income tax provision and depreciation and amortization. We define Adjusted EBITDA as EBITDA adjusted for equity-based compensation expense, debt extinguishment costs, gain on foreign currency derivatives and transaction-related expenses.

EBITDA, Adjusted EBITDA and Adjusted income from continuing operations are supplemental measures of our performance and are not required by, or presented in accordance with, generally accepted accounting principles in the United States (“GAAP”). EBITDA, Adjusted EBITDA and Adjusted income from continuing operations are not measures of our financial performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP or as an alternative to cash flow from operating activities as measures of our liquidity. Our measurements of EBITDA, Adjusted EBITDA and Adjusted income from continuing operations may not be comparable to similarly titled measures of other companies. We have included information concerning EBITDA, Adjusted EBITDA and Adjusted income from continuing operations in this press release because we believe that such information is used by certain investors as measures of a company’s historical performance. We believe these measures are frequently used by securities analysts, investors and other interested parties in the evaluation of issuers of equity securities, many of which present EBITDA, Adjusted EBITDA and Adjusted income from continuing operations when reporting their results. Our presentation of EBITDA, Adjusted EBITDA and Adjusted income from continuing operations should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

(a) Represents the equity-based compensation expense of Acadia.

(b) Represents debt extinguishment costs related to the repayment of $52.5 million of the Company’s 12.875% Senior Notes due 2018 on March 12, 2013, including a prepayment premium of $6.8 million and the write-off of $2.6 million of deferred financing costs.

(c) Represents the change in fair value of foreign currency derivatives purchased by Acadia related to its acquisition of Partnerships in Care on July 1, 2014.

(d) Represents transaction-related expenses incurred by Acadia related to acquisitions.

(e) Represents the income tax provision adjusted to reflect the tax effect of the adjustments to income from continuing operations based on tax rates of 28.0% for the three months ended September 30, 2014 and 33.4% for the nine months ended September 30, 2014.

 

- END -